港股異動 | 澳門新冠疫苗接種暫停,博彩股集體走低
uSMART盈立智投3月24日消息,歐洲多國迎第三波新冠疫情,隔夜美股博彩股大跌,今日港股博彩股亦集體走低。截至10:00,美高梅中國跌超18%後現已快速回升至跌5%,銀河娛樂盤中跌超4%,金沙中國、永利澳門跌近5%,澳博盤中跌超2%。
根據澳門政府新聞稿,衛生局收到復星實業(香港)公司的書面通知,注意到多個與批號爲210102的德國BioNTech生產的mRNA新冠疫苗Comirnaty®(有效期至2021年6月)西林瓶封蓋有關的包裝瑕疵,澳門今日起暫停接種此疫苗。
BioNTech和復星醫藥已發起對該問題的原因調查,BioNTech和復星醫藥表示,到目前爲止,還沒有理由認爲產品安全存在風險。
大和日前發研報指,澳門3月份至今博彩收入錄得58.5億元(澳門元,下同),每日平均收入爲2.78億元,當中3月15日-21日爲每日3.07億元,是自農曆新年後首次錄得逾3億元賭收,不過較該行及市場預期的3.4億元差。該行預期澳門4月份每日平均賭收將達2.5-2.7億元,按年跌67.6%-70%,但仍重申對行業的“正面”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.